Department of Urology, Spedali Civili of Brescia, Brescia, Italy -
Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland -
Minerva Urol Nephrol. 2022 Oct;74(5):570-580. doi: 10.23736/S2724-6051.21.04436-0. Epub 2021 Jul 15.
Despite bladder perforation (BP) is a frequent complication during transurethral resection of bladder (TURB) for bladder cancer (BCa), literature lacks systematic reviews focusing on this issue. We aimed to investigate incidence, diagnosis, therapy, and prognosis after BP during TURB for BCa; therapy was distinguished between conservative (without the need for bladder repair) and surgical management (requiring bladder wall closure).
A systematic search was conducted up to April 2021 using PubMed, Scopus, Cochrane Database of Systematic Reviews, and Web of Science to identify articles focusing on incidence, detection, management, or survival outcomes after iatrogenic BP. The selection of articles followed the preferred reporting items for systematic review and meta-analyses process.
We included 41 studies, involving 21,174 patients. Overall, 521 patients experienced BP during TURB for BCa, with a mean incidence of 2.4%, up to 58.3% when postoperative cystography is routinely performed after all TURB procedures. Risk factors were low body mass index (BMI) (P=0.01), resection depth (P=0.006 and P=0.03), and low surgical experience (P=0.006). Extraperitoneal BP (68.5%) were treated conservatively in 97.5% of patients; intraperitoneal BP were managed with surgical bladder closure in 56% of cases. Overall, three immediate BP-related deaths were recorded due to septic complications. Extravesical tumor seeding was observed after 6 intraperitoneal and 1 extraperitoneal BP (median time: 6.2 months). Intraperitoneal BP (P=0.0003) and bladder closure (P<0.001) were found as independent predictors of extravesical tumor recurrence.
BP is more frequent than expected when proper diagnosis is routinely performed after all TURB procedures. Risk factors include low BMI, resection depth, and unexperienced surgeon. The risk of sepsis after BP suggests empirical antibiotic prophylaxis after BP.
尽管膀胱穿孔(BP)是经尿道膀胱肿瘤切除术(TURB)治疗膀胱癌(BCa)的常见并发症,但文献缺乏对此问题的系统综述。我们旨在研究 TURB 治疗 BCa 过程中发生 BP 的发生率、诊断、治疗和预后;治疗方法分为保守治疗(无需膀胱修复)和手术治疗(需要膀胱壁闭合)。
截至 2021 年 4 月,我们使用 PubMed、Scopus、Cochrane 系统评价数据库和 Web of Science 进行了系统检索,以确定聚焦于医源性 BP 后发病率、检测、管理或生存结果的文章。文章选择遵循系统评价和荟萃分析的首选报告项目。
我们纳入了 41 项研究,共涉及 21174 例患者。总体而言,21174 例接受 TURB 治疗的 BCa 患者中有 521 例发生 BP,平均发生率为 2.4%,当所有 TURB 术后常规进行术后膀胱造影时,发生率高达 58.3%。危险因素包括低体重指数(BMI)(P=0.01)、切除深度(P=0.006 和 P=0.03)和低手术经验(P=0.006)。68.5%的腹膜外 BP 采用保守治疗,97.5%的患者接受治疗;56%的腹膜内 BP 采用手术膀胱闭合治疗。总体而言,有 3 例因感染性并发症而与 BP 相关的即刻死亡。6 例腹膜内和 1 例腹膜外 BP 后观察到膀胱外肿瘤种植(中位时间:6.2 个月)。腹膜内 BP(P=0.0003)和膀胱闭合(P<0.001)是膀胱外肿瘤复发的独立预测因素。
当所有 TURB 术后常规进行适当诊断时,BP 的发生率高于预期。危险因素包括低 BMI、切除深度和无经验的外科医生。BP 后发生脓毒症的风险提示 BP 后应进行经验性抗生素预防。